Your browser is no longer supported. Please, upgrade your browser.
Settings
BIOL BIOLASE, Inc. daily Stock Chart
BIOL [NASD]
BIOLASE, Inc.
Index- P/E- EPS (ttm)-0.33 Insider Own1.20% Shs Outstand68.61M Perf Week5.78%
Market Cap29.76M Forward P/E- EPS next Y-0.10 Insider Trans- Shs Float53.45M Perf Month-20.42%
Income-22.50M PEG- EPS next Q-0.04 Inst Own38.80% Short Float3.35% Perf Quarter-21.10%
Sales48.10M P/S0.62 EPS this Y17.00% Inst Trans3.69% Short Ratio6.25 Perf Half Y-59.84%
Book/sh0.28 P/B1.55 EPS next Y47.40% ROA-56.80% Target Price1.63 Perf Year-75.91%
Cash/sh0.07 P/C6.61 EPS next 5Y20.00% ROE-103.60% 52W Range0.28 - 1.90 Perf YTD-69.02%
Dividend- P/FCF- EPS past 5Y-14.60% ROI-67.80% 52W High-77.17% Beta2.39
Dividend %- Quick Ratio1.00 Sales past 5Y1.20% Gross Margin35.20% 52W Low54.89% ATR0.05
Employees225 Current Ratio2.00 Sales Q/Q-18.20% Oper. Margin-36.20% RSI (14)40.70 Volatility7.10% 12.97%
OptionableNo Debt/Eq0.00 EPS Q/Q16.10% Profit Margin-46.80% Rel Volume1.27 Prev Close0.42
ShortableYes LT Debt/Eq0.00 EarningsNov 07 AMC Payout- Avg Volume286.72K Price0.43
Recom1.50 SMA20-11.00% SMA50-26.07% SMA200-50.73% Volume362,964 Change3.26%
Apr-25-17Initiated Singular Research Buy $2.50
May-13-14Downgrade WallachBeth Buy → Hold $4 → $2.50
Nov-12-13Reiterated WallachBeth Buy $3.50 → $2.75
Aug-08-13Reiterated WallachBeth Buy $6.50 → $4.50
Jun-17-13Initiated WallachBeth Buy $6.50
Mar-18-13Reiterated Northland Capital Outperform $6 → $7
Mar-07-13Reiterated Northland Capital Outperform $6 → $7
Sep-07-12Initiated Northland Securities Outperform $4
Dec-11-17 01:34PM  ETFs with exposure to BIOLASE, Inc. : December 11, 2017 Capital Cube
Dec-01-17 10:27AM  ETFs with exposure to BIOLASE, Inc. : December 1, 2017 Capital Cube
Nov-30-17 08:00AM  BIOLASE Announces Expiration of Rights Offering Business Wire
Nov-22-17 08:00AM  BIOLASE to Conduct Demos of Portable Waterlase Express All-Tissue Laser System at Greater New York Dental Meeting Business Wire +7.27%
Nov-20-17 11:50AM  ETFs with exposure to BIOLASE, Inc. : November 20, 2017 Capital Cube
Nov-17-17 08:00AM  BIOLASE to Present at the LD Micro 10th Annual Main Event Conference ACCESSWIRE -5.10%
Nov-16-17 08:00AM  BIOLASE to Present at the Singular Research Best of the Uncovered 12th Annual Conference 2017 Business Wire
Nov-09-17 12:07PM  ETFs with exposure to BIOLASE, Inc. : November 9, 2017 Capital Cube
08:00AM  BIOLASE Announces Commencement of Rights Offering Business Wire
Nov-03-17 10:04AM  BIOLASE, Inc. :BIOL-US: Earnings Analysis: Q3, 2017 By the Numbers : November 3, 2017 Capital Cube
08:00AM  BIOLASE Announces Terms of Rights Offering Business Wire
Nov-01-17 07:45PM  Edited Transcript of BIOL earnings conference call or presentation 1-Nov-17 8:30pm GMT Thomson Reuters StreetEvents +5.63%
06:01PM  Biolase reports 3Q loss Associated Press
04:05PM  BIOLASE Reports 2017 Third Quarter and Nine-Month Results Business Wire
Oct-31-17 08:00AM  BIOLASE Appoints Richard B. Lanman to Board of Directors Business Wire +6.91%
Oct-30-17 11:27AM  ETFs with exposure to BIOLASE, Inc. : October 30, 2017 Capital Cube
08:00AM  BIOLASE Announces Record Date for Previously Announced Proposed Rights Offering Business Wire
Oct-25-17 08:00AM  BIOLASE® to Host 2017 Third Quarter Financial Results Conference Call on November 1 Business Wire
Oct-12-17 10:19AM  ETFs with exposure to BIOLASE, Inc. : October 12, 2017 Capital Cube
Oct-03-17 08:00AM  BIOLASE Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) Business Wire
Oct-02-17 07:37PM  Should You Be Holding BIOLASE Inc (BIOL) Right Now? Simply Wall St.
08:00AM  BIOLASE Names John Beaver Senior Vice President, Chief Financial Officer Business Wire
Sep-29-17 08:10AM  BIOLASE Announces Plans for Rights Offering to Stockholders Business Wire
Sep-05-17 08:10PM  ETFs with exposure to BIOLASE, Inc. : September 6, 2017 Capital Cube +5.74%
06:00AM  BIOLASE Names Jonathan T. Lord Chairman of the Board Business Wire
Aug-25-17 03:56PM  ETFs with exposure to BIOLASE, Inc. : August 25, 2017 Capital Cube
Aug-16-17 11:38AM  BIOLASE, Inc. :BIOL-US: Earnings Analysis: Q2, 2017 By the Numbers : August 16, 2017 Capital Cube
Aug-12-17 05:55AM  Edited Transcript of BIOL earnings conference call or presentation 7-Aug-17 8:30pm GMT Thomson Reuters StreetEvents
Aug-08-17 04:06PM  ETFs with exposure to BIOLASE, Inc. : August 8, 2017 Capital Cube -28.05%
Aug-07-17 11:57PM  Biolase reports 2Q loss Associated Press
04:05PM  BIOLASE Reports 2017 Second Quarter and Six-Month Results Business Wire
Jul-31-17 06:00AM  BIOLASE® to Host 2017 Second Quarter Financial Results Conference Call on August 7 Business Wire
Jul-13-17 03:38PM  ETFs with exposure to BIOLASE, Inc. : July 13, 2017 Capital Cube
Jun-26-17 03:25PM  ETFs with exposure to BIOLASE, Inc. : June 26, 2017 Capital Cube +6.38%
May-31-17 06:00AM  BIOLASE to Present at the 7th Annual LD Micro Invitational Accesswire
May-22-17 01:23PM  ETFs with exposure to BIOLASE, Inc. : May 22, 2017 Capital Cube
May-11-17 04:16PM  ETFs with exposure to BIOLASE, Inc. : May 11, 2017 Capital Cube
May-09-17 10:52AM  BIOLASE, Inc. :BIOL-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017 Capital Cube
May-08-17 09:18AM  Edited Transcript of BIOL earnings conference call or presentation 3-May-17 8:30pm GMT Thomson Reuters StreetEvents
May-05-17 06:00AM  BIOLASE Announces Management Change Business Wire
May-03-17 05:50PM  Biolase reports 1Q loss Associated Press
04:05PM  BIOLASE Reports 2017 First Quarter Results Business Wire
Apr-26-17 06:00AM  BIOLASE® to Host 2017 First Quarter Financial Results Conference Call on May 3 Business Wire +9.13%
Apr-13-17 06:00AM  BIOLASE to Raise $10.5 Million from Institutional and Individual Investors in a Private Placement Business Wire
Mar-28-17 06:00AM  BIOLASE Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) Business Wire
Mar-27-17 03:50PM  ETFs with exposure to BIOLASE, Inc. : March 27, 2017 Capital Cube
03:50PM  ETFs with exposure to BIOLASE, Inc. : March 27, 2017
Mar-20-17 11:48AM  BIOLASE, Inc. :BIOL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017 Capital Cube -10.77%
11:48AM  BIOLASE, Inc. :BIOL-US: Earnings Analysis: Q4, 2016 By the Numbers : March 20, 2017
06:00AM  BIOLASE to Showcase Two New Game-Changing Products at International Dental Show in Cologne Business Wire
Mar-16-17 01:04PM  BIOLASE, INC Financials +6.09%
Mar-15-17 02:11PM  BIOLASE, Inc. :BIOL-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017 Capital Cube
02:11PM  BIOLASE, Inc. :BIOL-US: Earnings Analysis: 2016 By the Numbers : March 15, 2017
Mar-14-17 10:47AM  BIOLASE, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
06:00AM  BIOLASE Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4) Business Wire
Mar-13-17 06:00AM  BIOLASE Names James D. Surek Vice President Sales, Americas Business Wire
Mar-10-17 04:10PM  BIOLASE, INC Files SEC form 10-K, Annual Report
Mar-09-17 06:00AM  BIOLASE to Present at the 29th Annual ROTH Conference Business Wire -12.41%
Mar-08-17 05:28PM  Biolase reports 4Q loss Associated Press
04:06PM  BIOLASE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  BIOLASE Reports 2016 Full Year and Fourth Quarter Results Business Wire
07:07AM  Q4 2016 BIOLASE Inc Earnings Release - After Market Close
Mar-01-17 04:08PM  BIOLASE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Principal Officer
04:05PM  BIOLASE Names Mark J. Nelson Chief Financial Officer Business Wire
06:00AM  BIOLASE® to Host 2016 Fourth Quarter Financial Results Conference Call on March 8 Business Wire
Feb-22-17 02:59PM  BIOLASE, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Feb-21-17 06:00AM  BIOLASE to Host Lasers for Every Dentist Launch Celebration at Chicago Midwinter Dental Meeting Business Wire
Feb-10-17 06:00AM  BIOLASE Announces the FDA Clearance and Worldwide Launch of New Waterlase Express All-Tissue Laser System Business Wire +7.89%
Jan-23-17 06:00AM  BIOLASE Announces the FDA Clearance and Worldwide Launch of Its New Epic Pro Diode Laser System Business Wire +14.29%
Jan-13-17 04:58PM  BIOLASE, INC Files SEC form 8-K, Change in Directors or Principal Officers -7.41%
Jan-09-17 05:02PM  BIOLASE, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -7.06%
06:00AM  BIOLASE Announces Management Change Business Wire
Jan-06-17 04:44PM  BIOLASE, INC Files SEC form 8-K, Change in Directors or Principal Officers
Jan-03-17 12:36PM  ETFs with exposure to BIOLASE, Inc. : January 3, 2017 +5.00%
Dec-13-16 06:24AM  BIOLASE Inc (BIOL): How It Stacks Up Against Its Peers at Insider Monkey
Dec-07-16 03:21PM  BIOLASE, INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
Nov-23-16 04:25PM  BIOLASE, INC Files SEC form 8-K, Change in Directors or Principal Officers
Nov-22-16 06:00AM  BIOLASE to Preview New Epic Pro Diode Laser at Greater New York Dental Meeting Business Wire
Nov-17-16 07:19AM  SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating BIOLASE, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors PR Newswire
Nov-14-16 12:57PM  ETFs with exposure to BIOLASE, Inc. : November 14, 2016 -8.09%
Nov-11-16 11:10AM  BIOLASE, Inc. :BIOL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 11, 2016 -5.98%
Nov-08-16 04:24PM  Biolase reports 3Q loss
04:08PM  BIOLASE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:05PM  BIOLASE Reports 2016 Third Quarter and Nine-Month Results Business Wire
07:07AM  Q3 2016 BIOLASE Inc Earnings Release - After Market Close
Nov-01-16 06:00AM  BIOLASE® to Host 2016 Third Quarter Financial Results Conference Call on November 8 Business Wire
Oct-31-16 06:00AM  BIOLASE Names Samuel B. Low, D.D.S., M.S., M.Ed., Vice President, Dental and Clinical Affairs & Chief Dental Officer Business Wire
Oct-06-16 02:07PM  BIOLASE, INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Submission of Matters to a Vote of Security
Sep-26-16 10:25AM  ETFs with exposure to BIOLASE, Inc. : September 26, 2016
Sep-22-16 06:00AM  BIOLASE Names Holger Arens Vice President, Managing Director EMEA Business Wire
Sep-12-16 05:15PM  BIOLASE Enters into Clinical Research Agreement with McGuire Institute for Landmark Laser Perio Research Project Business Wire
Aug-29-16 11:05AM  ETFs with exposure to BIOLASE, Inc. : August 29, 2016 +5.16%
Aug-08-16 05:20PM  BIOLASE, INC Files SEC form 8-K, Unregistered Sale of Equity Securities, Material Modification to Rights of Security +9.45%
Aug-02-16 01:41PM  BIOLASE, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Stat
Aug-01-16 09:13AM  BIOLASE, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits +6.19%
07:07AM  Q2 2016 BIOLASE Inc Earnings Release - After Market Close
06:20AM  Biolase reports 2Q loss
06:10AM  BIOLASE Reports 2016 Second Quarter and Six-Month Results Business Wire
06:00AM  BIOLASE to Raise $10 Million from Institutional and Individual Investors in Convertible Preferred Private Placement Business Wire
Jul-25-16 06:00AM  BIOLASE® to Host 2016 Second Quarter Financial Results Conference Call on August 1 Business Wire
BIOLASE, Inc., a medical device company, develops, manufactures, markets, and sells laser systems in dentistry and medicine in the United States and internationally. The company offers Waterlase dental laser systems for cutting soft and hard tissue; and diode laser systems, which are used to perform soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. Its dental laser systems allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a range of dental procedures, such as cosmetic, restorative, and complex surgical applications. The company also markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners. Its dental imaging products comprise 3Shape Trios intraoral scanner and digital impression systems for high-speed digital 3-D picture taking; Galaxy BioMill CAD/CAM system that enables dental practitioners to design, scan, mill, and finish crowns, inlays, and veneers inside the dental office; and CEFLA NewTom VGi and VG3 3-D cone beam computed tomography devices. In addition, the company manufactures and sells consumable products and accessories for its laser systems, as well as markets flexible fibers and hand pieces. It sells its products primarily to dentists in general practice through its field sales force and distributor network. BIOLASE, Inc. was founded in 1984 and is headquartered in Irvine, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FEINBERG LARRY N10% OwnerDec 05Buy0.4610,745,6154,900,00030,866,265Dec 06 04:33 PM
FEINBERG LARRY N10% OwnerDec 04Buy0.301,800,000540,00020,120,650Dec 06 04:33 PM
SCHULER JACK W10% OwnerJan 04Buy1.5224,25536,94310,238,756Jul 13 05:10 PM
SCHULER JACK W10% OwnerJan 03Buy1.449,10013,14610,214,501Jul 13 05:10 PM
SCHULER JACK W10% OwnerDec 30Buy1.398,00211,12410,205,401Jul 13 05:10 PM
SCHULER JACK W10% OwnerDec 29Buy1.412,2003,09610,197,399Jul 13 05:10 PM